Our projects - I think the summary text below could be improved and simplified
RAPID aims to support point of care testing scale up research being conducted across a range of settings (including low- and middle-income countries, remote or high-income country urban settings), diseases, health service types (primary care, antenatal, drug and alcohol etc) and available resources. Through an expression of interest process, RAPID provides Investigators and colleagues with additional health economics, modelling, social science and epidemiological research support to enhance existing point of care testing projects that directly address the scale up of point of care testing, or contribute to the broader aims of the research consortium.
Jump to a project category
Universal projects
Some subtext describing what this section covers
Understanding the health system implications for delivering integrated POCT for infectious disease in primary care settings.
| Year 2020 |
Named PI/Co-PI C. Treloar |
Scoping review.
| Year 2023 |
Named PI/Co-PI R. Guy, T. Applegate, A. Kindinger, Y. Zhang. |
Effectiveness, cost-effectiveness, barriers and facilitators and implementation strategies for point-of-care testing for HIV, viral hepatitis and STIs: a series of systematic reviews.
| Year 2023 |
Named PI/Co-PI G.Fontaine, J.Grebely |
Narrative review Social Science – acceptability.
| Year 2023 |
Named PI/Co-PI L. Lafferty. |
Policy narrative.
| Year 2023 |
Named PI/Co-PI Y.Zhang. |
Hepatitis C projects
Some subtext describing what this section covers
Scale-up of point-of-care testing strategies to enhance hepatitis C treatment among people who inject drugs: Modelling, affordability and cost-effectiveness analysis.
| Year 2020 |
Named PI/Co-PI J. Grebley, S. Shih, R. Gray, V. Wiseman. |
Attitudes and barriers towards the acceptability of integrating finger-stick point-of-care testing to enhance treatment uptake in the prison setting: Perspectives of people in prison health personnel, correctional personnel and stakeholders (The PIVOT Study).
| Year 2020 |
Named PI/Co-PI L. Lafferty. |
The perspectives of clinic staff in integrating and scaling up point-of-care testing for hepatitis C infection in non-specialised settings: a qualitative study.
| Year 2021 |
Named PI/Co-PI Alison Marshall. |
Evaluation of operator training, quality assurance, and quality control program for point-of-care testing for HCV infection.
| Year 2021 |
Named PI/Co-PI S. Matthews, C. Markus, J. Grebely, . |
HIV projects
Some subtext describing what this section covers
The effectiveness, health system implementation requirements, cost effectiveness and acceptability of point-of-care HIV viral load testing and HIV drug resistance monitoring for the management and control of HIV in Papua New Guinea (PNG).
| Year 2021 |
Named PI/Co-PI A.Kelly-Hanku. |
MENJAGA – long term costs / health outcomes.
| Year 2023 |
Named PI/Co-PI Q.Cheng. |
STI projects
Some subtext describing what this section covers
Impact of the introduction of the new trichomonas point-of-care tests used by primary care staff in remote Aboriginal communities on the uptake and timeliness of Trichomoniasis.
| Year 2021 |
Named PI/Co-PI A. Tangey |
Perceptions and acceptability among healthcare workers on the uptake of molecular point-of-care testing for Trichomonas and enablers and barriers.
| Year 2021 |
Named PI/Co-PI A. Tangey |
Tuberculosis projects
Some subtext describing what this section covers
Patient preferences and use of point-of-care testing for tuberculosis in Vietnam and Australia.
| Year 2021 |
Named PI/Co-PI G. Fox. |